Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2010 August;51(4) > The Journal of Cardiovascular Surgery 2010 August;51(4):567-71

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEWS  TREATMENT OF IN-STENT RESTENOSIS IN PERIPHERAL ARTERIES


The Journal of Cardiovascular Surgery 2010 August;51(4):567-71

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: English

Paclitaxel-coated balloon angioplasty for lower extremity revascularization: a new way to fight in-stent restenosis

Manzi M., Cester G., Palena L. M.

Interventional Radiology Unit, Policlinico Abano Terme, Abano Terme, Padua, Italy


PDF  


In the last years the development of new techniques and technologies for the endovascular treatment of peripheral arterial occlusive disease has allowed to treat a vast array of lesions with high technical success and low complications. Despite these advances, restenosis, and in particular in-stent restenosis, is a problem that significantly affects middle and long-term results and remains to be solved. Drug-eluting balloons (DEB) have shown good results in the treatment of coronary in-stent restenosis in experimental and clinical trials, but only few experimental and clinical trials focus on the peripheral district. This review summarizes the available experimental and clinical data in support of DEB in the treatment of ISR in the peripheral district. Larger clinical trials focused on paclitaxel-coated balloon in the treatment of ISR in the peripheral arteries will be necessary to provide definitive evidence of clinical benefit.

top of page

Publication History

Cite this article as

Corresponding author e-mail

marco.manzi2@tin.it